Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study

---

Urun Y., Abali H., Turna H., Esin E., Sedef A. M., Alkan A., ...More

European Cancer Congress, Vienna, Austria, 01 January 2015, vol.51, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 51
• Doi Number: 10.1016/s0959-8049(16)31872-x
• City: Vienna
• Country: Austria
• Hacettepe University Affiliated: Yes